QUESTIONSUpdate on Indications, Interactions and Complications in the Use of Pharmaceuticals
Venue: Norwegian Cruise Line\'s Pride of America
Location: From Honolulu, Hawaii, United States
| Event Date/Time: Apr 11, 2009 | End Date/Time: Apr 18, 2009 |
| Registration Date: Apr 08, 2009 |
Report as SpamDescription
Target Audience
Pharmacists, Primary Care Physicians, Nurses
Program Purpose / Objectives
After attending the following session individuals should be able to:
1. Outline strategies for assessing and counseling patients on the use of OTC products.
2. Describe patients attitude about monitoring and diagnostics for self-care.
3. Explain issues related to drug safety, patient information, and other recent FDA activities such as prescription drug labeling, MedWatch, and post-marketing safety surveillance.
4. Describe the mechanism of action and indications for newly approved drugs.
5. Identify challenges and safety concerns regarding the medication approval and post-market surveillance processes.
6. Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors within health care.
7. Describe the benefits and limitations of collaborative practice models in various patient care settings.
********************************************************************************
Patient’s Role in Self-Care: Working with Their Health Care Providers
1. Outline strategies for assessing and counseling patients on the use of OTC products.
Monitoring and Diagnostic Devices for Self-Care
1. Describe patients attitude about monitoring and diagnostics for self-care.
FDA and Regulatory Update on Pharmaceuticals
1. Explain issues related to drug safety, patient information, and other recent FDA activities such as prescription drug labeling, MedWatch, and post-marketing safety surveillance
New Product Approvals for 2007
1. Describe the mechanism of action and indications for newly approved drugs.
Medication Safety and Medication Errors in the Medication Use Process
1. Identify challenges and safety concerns regarding the medication approval and post-market surveillance processes.
Minimizing Medication Errors and Liability Through Technology
1. Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors within health care.
Developing Collaborative Care Models
1. Describe the benefits and limitations of collaborative practice models in various patient care settings.
Pharmacists, Primary Care Physicians, Nurses
Program Purpose / Objectives
After attending the following session individuals should be able to:
1. Outline strategies for assessing and counseling patients on the use of OTC products.
2. Describe patients attitude about monitoring and diagnostics for self-care.
3. Explain issues related to drug safety, patient information, and other recent FDA activities such as prescription drug labeling, MedWatch, and post-marketing safety surveillance.
4. Describe the mechanism of action and indications for newly approved drugs.
5. Identify challenges and safety concerns regarding the medication approval and post-market surveillance processes.
6. Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors within health care.
7. Describe the benefits and limitations of collaborative practice models in various patient care settings.
********************************************************************************
Patient’s Role in Self-Care: Working with Their Health Care Providers
1. Outline strategies for assessing and counseling patients on the use of OTC products.
Monitoring and Diagnostic Devices for Self-Care
1. Describe patients attitude about monitoring and diagnostics for self-care.
FDA and Regulatory Update on Pharmaceuticals
1. Explain issues related to drug safety, patient information, and other recent FDA activities such as prescription drug labeling, MedWatch, and post-marketing safety surveillance
New Product Approvals for 2007
1. Describe the mechanism of action and indications for newly approved drugs.
Medication Safety and Medication Errors in the Medication Use Process
1. Identify challenges and safety concerns regarding the medication approval and post-market surveillance processes.
Minimizing Medication Errors and Liability Through Technology
1. Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors within health care.
Developing Collaborative Care Models
1. Describe the benefits and limitations of collaborative practice models in various patient care settings.
Venue
Cruise
MORE INFO ON THIS VENUE 